Pathophysiology of idiopathic gastroparesis and implications for therapy

References

• Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592–1622.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18–37.
   PubMed Web of Science ®Google Scholar
• Jung HK, Choung RS, Locke GR, 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–1233.
   PubMed Web of Science ®Google Scholar
• Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–2404.
   PubMed Web of Science ®Google Scholar
• Parkman HP, Yates K, Hasler WL, et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol. 2011;9:1056–1064.
   PubMed Web of Science ®Google Scholar
• Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140:101–115.
   PubMed Web of Science ®Google Scholar
• Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003;18:141–150.
   PubMed Web of Science ®Google Scholar
• Cherian D, Sachdeva P, Fisher RS, et al. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol. 2010;8:676–681.
   PubMed Web of Science ®Google Scholar
• Hoogerwerf WA, Pasricha PJ, Kalloo AN, et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterology. 1999;94:1029–1033.
   PubMed Web of Science ®Google Scholar
• Nguyen LA, Snape WJ, Jr. Clinical presentation and pathophysiology of gastroparesis. Gastroenterol Clin North Am. 2015;44:21–30.
   PubMed Web of Science ®Google Scholar
• Forster J, Damjanov I, Lin Z, et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg. 2005;9:102–108.
   PubMed Web of Science ®Google Scholar
• Lin Z, Sarosiek I, Forster J, et al. Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis. Neurogastroenterol Motil. 2010;22:56–61, e10.
   PubMed Web of Science ®Google Scholar
• Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140:1575–1585 e8.
   PubMed Web of Science ®Google Scholar
• Grover M, Bernard CE, Pasricha PJ, et al. Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil. 2012;24:531–539, e249.
   PubMed Web of Science ®Google Scholar
• Heckert J, Thomas RM, Parkman HP. Gastric neuromuscular histology in patients with refractory gastroparesis: Relationships to etiology, gastric emptying, and response to gastric electric stimulation. Neurogastroenterol Motil. 2017;29:e13068.
   Web of Science ®Google Scholar
• Harberson J, Thomas RM, Harbison SP, et al. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci. 2010;55:359–370.
   PubMed Web of Science ®Google Scholar
• Moraveji S, Bashashati M, Elhanafi S, et al. Depleted interstitial cells of Cajal and fibrosis in the pylorus: novel features of gastroparesis. Neurogastroenterol Motil. 2016;28:1048–1054.
   PubMed Web of Science ®Google Scholar
• Bashashati M, Moraveji S, Torabi A, et al. Pathological findings of the antral and pyloric smooth muscle in patients with gastroparesis-like syndrome compared to gastroparesis: similarities and differences. Dig Dis Sci. 2017;62:2828–2833.
   PubMed Web of Science ®Google Scholar
• Faussone-Pellegrini MS, Grover M, Pasricha PJ, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med. 2012;16:1573–1581.
   PubMed Web of Science ®Google Scholar
• Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroenterol Motil. 2008;20:54–63.
   PubMed Web of Science ®Google Scholar
• Lahr CJ, Griffith J, Subramony C, et al. Gastric electrical stimulation for abdominal pain in patients with symptoms of gastroparesis. Am Surg. 2013;79:457–464. May
   PubMed Web of Science ®Google Scholar
• Herring BP, Hoggatt AM, Gupta A, et al. Idiopathic gastroparesis is associated with specific transcriptional changes in the gastric muscularis externa. Neurogastroenterol Motil. 2018;30:e13230.
   PubMed Web of Science ®Google Scholar
• Grover M, Bernard CE, Pasricha PJ, et al. Gastroparesis Clinical Research Consortium (GpCRC), Diabetic and idiopathic gastroparesis is associated with loss of CD206-positive macrophages in the gastric antrum. Neurogastroenterol Motil. 2017;29:e13018.
   Web of Science ®Google Scholar
• Choi KM, Kashyap PC, Dutta N, et al. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology. 2010;138:2399–2409, 2409 e1.
   PubMed Web of Science ®Google Scholar
• Cipriani G, Gibbons SJ, Miller KE, et al. Change in populations of macrophages promotes development of delayed gastric emptying in mice. Gastroenterology. 2018;154(8):2122–2136.e12.
   PubMed Web of Science ®Google Scholar
• Choi KM, Gibbons SJ, Nguyen TV, et al. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology. 2008;135:2055–2064, 2064 e1–2064 e2.
   PubMed Web of Science ®Google Scholar
• Choi KM, Gibbons SJ, Sha L, et al. Interleukin 10 restores gastric emptying, electrical activity, and interstitial cells of Cajal networks in diabetic mice. Cell Mol Gastroenterol Hepatol. 2016;2:454–467.
   PubMed Web of Science ®Google Scholar
• Gibbons SJ, Grover M, Choi KM, et al. Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis. PLoS One. 2017;12:e0187772.
   PubMed Web of Science ®Google Scholar
• Grover M, Gibbons SJ, Nair AA, et al. Transcriptomic signatures reveal immune dysregulation in human diabetic and idiopathic gastroparesis. BMC Med Genomics. 2018;11:62.
   PubMed Web of Science ®Google Scholar
• Grover M, Bernard CE, Pasricha PJ, et al. Platelet-derived growth factor receptor alpha (PDGFRalpha)-expressing "fibroblast-like cells" in diabetic and idiopathic gastroparesis of humans. Neurogastroenterol Motil. 2012;24:844–852.
   PubMed Web of Science ®Google Scholar
• Koch KL. Gastric dysrhythmias: a potential objective measure of nausea. Exp Brain Res. 2014;232:2553–2561.
   PubMed Web of Science ®Google Scholar
• Chen JD, Schirmer BD, McCallum RW. Serosal and cutaneous recordings of gastric myoelectrical activity in patients with gastroparesis. Am J Physiol. 1994;266:G90–G98.
   PubMed Web of Science ®Google Scholar
• O'Grady G, Angeli TR, Du P, et al. Abnormal initiation and conduction of slow-wave activity in gastroparesis, defined by high-resolution electrical mapping. Gastroenterology. 2012;143:589–598 e3.
   PubMed Web of Science ®Google Scholar
• Chen JD, Lin Z, Pan J, et al. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Digest Dis Sci. 1996;41:1538–1545.
   PubMed Web of Science ®Google Scholar
• Brzana RJ, Koch KL, Bingaman S. Gastric myoelectrical activity in patients with gastric outlet obstruction and idiopathic gastroparesis. Am J Gastroenterology. 1998;93:1803–1809.
   PubMed Web of Science ®Google Scholar
• Rothstein RD, Alavi A, Reynolds JC. Electrogastrography in patients with gastroparesis and effect of long-term cisapride. Dig Dis Sci. 1993;38:1518–1524.
   PubMed Web of Science ®Google Scholar
• Desai A, O'Connor M, Neja B, et al. Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms. Neurogastroenterol Motil. 2018;30:e13365.
   PubMed Web of Science ®Google Scholar
• Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008;36:44–54.
   PubMedGoogle Scholar
• Sachdeva P, Malhotra N, Pathikonda M, et al. Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci. 2011;56:1138–1146.
   PubMed Web of Science ®Google Scholar
• Ziessman HA, Chander A, Clarke JO, et al. The added diagnostic value of liquid gastric emptying compared with solid emptying alone. J Nucl Med. 2009;50:726–731.
   PubMed Web of Science ®Google Scholar
• Ziessman HA, Okolo PI, Mullin GE, et al. Liquid gastric emptying is often abnormal when solid emptying is normal. J Clin Gastroenterol. 2009;43:639–643.
   PubMed Web of Science ®Google Scholar
• Parkman HP, Hallinan EK, Hasler WL, et al. Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing. Neurogastroenterol Motil. 2017;29:e12981.
   Web of Science ®Google Scholar
• Cassilly DW, Wang YR, Friedenberg FK, et al. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion. 2008;78:144–151.
   PubMed Web of Science ®Google Scholar
• Karamanolis G, Caenepeel P, Arts J, et al. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction?. Gut. 2007;56:29–36.
   PubMed Web of Science ®Google Scholar
• Cassilly D, Kantor S, Knight LC, et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil. 2008;20:311–319.
   PubMed Web of Science ®Google Scholar
• Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2007;27:186–196.
   PubMed Web of Science ®Google Scholar
• Hasler WL, Patrick May KP, Wilson LA, et al. Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis. Neurogastroenterol Motil. 2018;30:e13196.
   Web of Science ®Google Scholar
• Lee A, Wilding G, Kuo B. Variable abnormal physiological motility in the proximal upper gastrointestinal tract in gastroparesis. Neurogastroenterol Motil. 2012;24:652–657, e276.
   PubMed Web of Science ®Google Scholar
• Sarosiek I, Selover KH, Katz LA, et al. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther. 2010;31:313–322.
   PubMed Web of Science ®Google Scholar
• Labo G, Bortolotti M, Vezzadini P, et al. Interdigestive gastroduodenal motility and serum motilin levels in patients with idiopathic delay in gastric emptying. Gastroenterology. 1986;90:20–26.
   PubMed Web of Science ®Google Scholar
• Orthey P, Yu D, Van Natta ML, et al. Intragastric meal distribution during gastric emptying scintigraphy for assessment of fundic accommodation: correlation with symptoms of gastroparesis. J Nucl Med. 2018;59:691–697.
   PubMed Web of Science ®Google Scholar
• Ajaj W, Goehde SC, Papanikolaou N, et al. Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders. Gut. 2004;53:1256–1261.
   PubMed Web of Science ®Google Scholar
• Malik Z, Sankineni A, Parkman HP. Assessing pyloric sphincter pathophysiology using EndoFLIP in patients with gastroparesis. Neurogastroenterol Motil. 2015;27:524–531.
   PubMed Web of Science ®Google Scholar
• Snape WJ, Lin MS, Agarwal N, et al. Evaluation of the pylorus with concurrent intraluminal pressure and EndoFLIP in patients with nausea and vomiting. Neurogastroenterol Motil. 2016;28:758–764.
   PubMed Web of Science ®Google Scholar
• Gourcerol G, Tissier F, Melchior C, et al. Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther. 2015;41:360–367.
   PubMed Web of Science ®Google Scholar
• Zikos TA, Clarke JO, Triadafilopoulos G, et al. A positive correlation between gastric and esophageal dysmotility suggests common causality. Dig Dis Sci. 2018 Dec;63(12):3417–3424.
   PubMed Web of Science ®Google Scholar
• Boltin D, Zvidi I, Steinmetz A, et al. Vomiting and dysphagia predict delayed gastric emptying in diabetic and nondiabetic subjects. J Diabetes Res. 2014;2014:1.
   Google Scholar
• Surjanhata B, Brun R, Wilding G, et al. Small bowel fed response as measured by wireless motility capsule: comparative analysis in healthy, gastroparetic, and constipated subjects. Neurogastroenterol Motil. 2018;30:e13268.
   PubMed Web of Science ®Google Scholar
• Oh JJ, Kim CH. Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history. Mayo Clin Proc. 1990;65:636–642.
   PubMed Web of Science ®Google Scholar
• Barkin JA, Czul F, Barkin JS, et al. Gastric enterovirus infection: a possible causative etiology of gastroparesis. Dig Dis Sci. 2016;61:2344–2350.
   PubMed Web of Science ®Google Scholar
• Naftali T, Yishai R, Zangen T, et al. Post-infectious gastroparesis: clinical and electerogastrographic aspects. J Gastroenterol Hepatol. 2007;22:1423–1428.
   PubMed Web of Science ®Google Scholar
• Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis-clinical characteristics and long-term outcomes. Am J Gastroenterol. 1997;92:1501–1504.
   PubMed Web of Science ®Google Scholar
• Pasricha PJ, Yates KP, Nguyen L, et al. Outcomes and factors associated with reduced symptoms in patients with gastroparesis. Gastroenterology. 2015;149:1762–1774.e4.
   PubMed Web of Science ®Google Scholar
• Parkman HP, Van Natta ML, Abell TL, et al. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial. JAMA. 2013;310:2640–2649.
   PubMed Web of Science ®Google Scholar
• Heckert J, Sankineni A, Hughes WB, et al. Gastric electric stimulation for refractory gastroparesis: a prospective analysis of 151 patients at a single center. Dig Dis Sci. 2016;61:168–175.
   PubMed Web of Science ®Google Scholar
• Williams PA, Nikitina Y, Kedar A, et al. Long-term effects of gastric stimulation on gastric electrical physiology. J Gastrointest Surg. 2013;17:50–55; discussion p. 55–56.
   PubMed Web of Science ®Google Scholar
• Richmond B, Chong B, Modak A, et al. Gastric electrical stimulation for refractory gastroparesis: predictors of response and redefining a successful outcome. Am Surg. 2015;81:467–471.
   PubMed Web of Science ®Google Scholar
• Anand C, Al-Juburi A, Familoni B, et al. Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers. Digestion. 2007;75:83–89.
   PubMed Web of Science ®Google Scholar
• McCallum RW, Lin Z, Forster J, et al. Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years. Clin Gastroenterol Hepatol. 2011;9:314–319 e1.
   PubMed Web of Science ®Google Scholar
• Velanovich V. Quality of life and symptomatic response to gastric neurostimulation for gastroparesis. J Gastrointest Surg. 2008;12:1656–1662; discussion 1662–1663.
   PubMed Web of Science ®Google Scholar
• Brody F, Vaziri K, Saddler A, et al. Gastric electrical stimulation for gastroparesis. J Am Coll Surg. 2008;207:533–538.
   PubMed Web of Science ®Google Scholar
• Mason RJ, Lipham J, Eckerling G, et al. Gastric electrical stimulation: an alternative surgical therapy for patients with gastroparesis. Arch Surg. 2005;140:841–846; discussion 847–848.
   PubMedGoogle Scholar
• Abell T, Lou J, Tabbaa M, et al. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. JPEN J Parenter Enteral Nutr. 2003;27:277–281.
   PubMed Web of Science ®Google Scholar
• Forster J, Sarosiek I, Lin Z, et al. Further experience with gastric stimulation to treat drug refractory gastroparesis. Am J Surg. 2003;186:690–695. Dec
   PubMed Web of Science ®Google Scholar
• McKenna D, Beverstein G, Reichelderfer M, et al. Gastric electrical stimulation is an effective and safe treatment for medically refractory gastroparesis. Surgery. 2008;144:566–572; discussion 572–574.
   PubMed Web of Science ®Google Scholar
• Timratana P, El-Hayek K, Shimizu H, et al. Laparoscopic gastric electrical stimulation for medically refractory diabetic and idiopathic gastroparesis. J Gastrointest Surg. 2013;17:461–470.
   PubMed Web of Science ®Google Scholar
• Abell T, McCallum R, Hocking M, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology. 2003;125:421–428.
   PubMed Web of Science ®Google Scholar
• McCallum RW, Sarosiek I, Parkman HP, et al. Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil. 2013;25:815–e636.
   PubMed Web of Science ®Google Scholar
• Bromer MQ, Friedenberg F, Miller LS, et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc. 2005;61:833–839.
   PubMed Web of Science ®Google Scholar
• Arts J, van Gool S, Caenepeel P, et al. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther. 2006;24:661–667.
   PubMed Web of Science ®Google Scholar
• Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterology. 2002;97:1653–1660.
   PubMed Web of Science ®Google Scholar
• Friedenberg FK, Palit A, Parkman HP, et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterology. 2008;103:416–423.
   PubMed Web of Science ®Google Scholar
• Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther. 2007;26:1251–1258.
   PubMed Web of Science ®Google Scholar
• Shada AL, Dunst CM, Pescarus R, et al. Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis. Surg Endosc. 2016;30:1326–1332.
   PubMed Web of Science ®Google Scholar
• Khashab MA, Ngamruengphong S, Carr-Locke D, et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2017;85:123–128.
   PubMed Web of Science ®Google Scholar
• Malik Z, Kataria R, Modayil R, et al.Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience. Dig Dis Sci. 2018 Sep;63(9):2405–2412.
   PubMed Web of Science ®Google Scholar
• Landreneau JP, Strong AT, El-Hayek K, et al. Laparoscopic pyloroplasty versus endoscopic per-oral pyloromyotomy for the treatment of gastroparesis. Surg Endosc. 2018. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Rodriguez JH, Haskins IN, Strong AT, et al. Per oral endoscopic pyloromyotomy for refractory gastroparesis: initial results from a single institution. Surg Endosc. 2017;31:5381–5388.
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Strong AT, Haskins IN, et al. Per-oral pyloromyotomy (POP) for medically refractory gastroparesis: short term results from the first 100 patients at a high volume center. Ann Surg. 2018;268:421–430.
   PubMed Web of Science ®Google Scholar
• Sarosiek I, Forster J, Lin Z, et al. The addition of pyloroplasty as a new surgical approach to enhance effectiveness of gastric electrical stimulation therapy in patients with gastroparesis. Neurogastroenterol Motil. 2013;25:134–e80.
   PubMed Web of Science ®Google Scholar
• Arthur LE, Slattery L, Richardson W. Tailored approach to gastroparesis significantly improves symptoms. Surg Endosc. 2018;32:977–982.
   PubMed Web of Science ®Google Scholar
• Musunuru S, Beverstein G, Gould J. Preoperative predictors of significant symptomatic response after 1 year of gastric electrical stimulation for gastroparesis. World J Surg. 2010;34:1853–1858.
   PubMed Web of Science ®Google Scholar
• Maranki JL, Lytes V, Meilahn JE, et al. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci. 2008;53:2072–2078.
   PubMed Web of Science ®Google Scholar
• Omer E, Kedar A, Nagarajarao HS, et al. Cajal cell counts are important predictors of outcomes in drug refractory gastroparesis patients with neurostimulation. J Clin Gastroenterol. 2018;1.
   Google Scholar
• Jacques J, Pagnon L, Hure F, et al. Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function. Endoscopy. 2018. [Epub ahead of print].
   Web of Science ®Google Scholar
• Wellington J, Scott B, Kundu S, et al. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis. Auton Neurosci Basic Clin. 2017;202:56–61.
   PubMed Web of Science ®Google Scholar
• Ashat M, Lewis A, Liaquat H, et al. Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis—an open-label study. Neurogastroenterol Motil. 2018;30:e13256. [Epub ahead of publication].
   Web of Science ®Google Scholar
• van Lelyveld N, Ter Linde J, Schipper M, et al. Serotonergic signalling in the stomach and duodenum of patients with gastroparesis. Neurogastroenterol Motil. 2008;20:448–455.
   PubMed Web of Science ®Google Scholar
• Richards RD, Valenzuela GA, Davenport KG, et al. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis. Dig Dis Sci. 1993;38:811–816.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000 Feb 29 -. Identifier NCT02510976, Prucalopride Versus Placebo in Gastroparesis; 2015 Jul 29 [cited 2018 Nov 27]; [about 6 screens]. Available from: https://ClinicalTrials.gov/show/NCT02510976
   Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000 Feb 29 -. Identifier NCT02267525, The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study; 2014 Oct 17 [cited 2018 Nov 27]; [about 5 screens]. Available from: https://ClinicalTrials.gov/show/NCT02267525
   Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000 Feb 29 -. Identifier NCT01718938, Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis; 2012 Nov 1 [cited 2018 Nov 27]; [about 6 screens]. Available from: https://ClinicalTrials.gov/show/NCT01718938
   Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000 Feb 29 -. Identifier NCT03281577, Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants; 2017 sept 13 [cited 2018 Nov 27; [about 7 screens]. Available from: https://ClinicalTrials.gov/show/NCT03281577
   Google Scholar
• Camilleri M, McCallum RW, Tack J, et al. Efficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, placebo-controlled study. Gastroenterology. 2017;153:1240–1250 e2.
   PubMed Web of Science ®Google Scholar
• Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther. 2005;22:847–853.
   PubMed Web of Science ®Google Scholar
• Gaddipati KV, Simonian HP, Kresge KM, et al. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci. 2006;51:1339–1346.
   PubMed Web of Science ®Google Scholar
• Pasricha PJ, Yates KP, Sarosiek I, et al. Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders. Gastroenterology. 2018;154:65–76 e11.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000 Feb 29 -. Identifier NCT0326894, A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG); 2017 Aug 31 [cited 2018 Nov 27]; [about 8 screens]. Available from: https://ClinicalTrials.gov/show/NCT03268941
   Google Scholar
• Roldan CJ, Chambers KA, Paniagua L, et al. Randomized controlled double-blind trial comparing haloperidol combined with conventional therapy to conventional therapy alone in patients with symptomatic gastroparesis. Acad Emerg Med. 2017;24:1307–1314.
   PubMed Web of Science ®Google Scholar
• Mansi C, Borro P, Giacomini M, et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther. 2000;14:561–569.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000 Feb 29 -. Identifier NCT01625923, A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis; 2012 Jul 22 [cited 2018 Nov 27]; [about 7 screens]. Available from: https://ClinicalTrials.gov/show/NCT01625923
   Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000 Feb 29 -. Identifier Vagal Nerve Stimulation for Gastroparesis; 2017 Apr 19 [cited 2018 Nov 27]; [about 6 screens]. Available from: https://ClinicalTrials.gov/show/NCT03120325
   Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000 Feb 29 -. Identifier NCT03603730, Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis; 2018 Jul 27 [cited 2018 Nov 27]; [about 7 screens]. Available from: https://clinicaltrials.gov/ct2/show/NCT03603730
   Google Scholar
• Tack J, Pokrotnieks J, Urbonas G, et al. Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)-results from the European phase 3 open-label safety trial. Neurogastroenterol Motil. 2018;30:e13284.
   PubMed Web of Science ®Google Scholar
• Sangnes DA, Softeland E, Biermann M, et al. Gastroparesis - causes, diagnosis and treatment. Tidsskriftet. 2016;136:822–826.
   Google Scholar
• Olausson EA, Storsrud S, Grundin H, et al. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol. 2014;109:375–385.
   PubMed Web of Science ®Google Scholar